Cuba's research and development of Latin America's first new crown vaccine has an effective rate of over 92%
Cuba's research and development of Latin America's first new crown vaccine has an effective rate of over 92% Cuba's research and development of Latin America's first new crown vaccine has an effective rate of over 92%
(Fighting New Coronary Pneumonia) Cuba's first new coronavirus vaccine in Latin America has an effective rate of over 92%
China News Service, Beijing, June 23.
Havana News: On the 21st local time, the Cuban Biomedical Group announced that its self-developed new crown vaccine "Avdala" has an effective rate of 92.
28%, making Cuba the first self-developed and manufactured company.
Latin American countries for the new crown vaccine
According to Agence France-Presse, the Cuban Biomedical Group issued an announcement stating that the new crown vaccine "Avdara" developed by the Cuban Genetics and Bioengineering Center has an effective rate of 92.
28% after three doses, making it the most effective in the world.
One of the new crown vaccines
It is reported that "Avdala" has entered the final stage of clinical trials and will be officially authorized by relevant Cuban institutions at the end of June or early July
In addition, the Finlay Institute of Vaccines in Cuba announced on the 19th that its three-dose new crown vaccine "Sovereign 02" can reach an effective rate of 62% after two doses.
This vaccine will also be approved in the near future
Cuban President Diaz-Canel praised on social media: “Even after the epidemic, the scientists at the Finlay Institute for Vaccine Research and the Center for Genetics and Bioengineering have overcome numerous obstacles and developed two exceptional models for us.
Effective COVID-19 vaccine
According to Turkey's Anadolu News Agency, Venezuela, Argentina, Mexico, Iran and other countries have expressed interest in purchasing Cuban self-developed vaccines
Since 2017, the U.
government has implemented more than 240 measures to strengthen the blockade against Cuba, among which a number of new restrictions during the epidemic have severely hindered Cuba’s access to vaccine production materials
In May of this year, Cuba began mass vaccination in Havana, aimed at combating the "beta" mutant virus first discovered in South Africa
According to Cuban official statistics, nearly 1 million of the country's approximately 11.
2 million people have completed the vaccination, and it is expected that approximately 1.
7 million people will be vaccinated in the coming weeks